Sohaib Ashraf: Clinical Trials

4 trials sponsored by Sohaib Ashraf, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 13Unknown 3
Phase 31Unknown 1

Follow Sohaib Ashraf: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Honey and Nigella Sativa in COVID-19 Prophylaxis
Honey, Nigella sativa seed, Placebo - Covid19
Phase 2 / Phase 3UnknownSohaib Ashraf10002021-03-052021-07-02
Role of Alprazolam in the Management of Acute Coronary Syndrome
Alprazolam, Placebo - Acute Coronary Syndrome, Myocardial Infarction
Phase 1 / Phase 2UnknownSohaib Ashraf482020-12-252021-01-20
Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients
Ivermectin Injectable Solution, Injectable Placebo, Zinc - Coronavirus Infection, COVID
Phase 1 / Phase 2UnknownSohaib Ashraf1802020-11-142021-02-17
Efficacy of Iodine Complex Against COVID-19 Patients
Iodine Complex, Placebo, Idoine Complex - Covid19, SARS-CoV-2
Phase 1 / Phase 2UnknownSohaib Ashraf2002020-07-142021-07-07

Conditions studied

COVID-19 (3)  ·  Coronavirus Infections (2)  ·  Acute Coronary Syndrome (1)  ·  Anxiety Disorders (1)  ·  Heart Diseases (1)  ·  Myocardial Infarction (1)  ·  ST Elevation Myocardial Infarction (1)

Interventions

Alprazolam (1)  ·  Capsules (1)  ·  Honey (1)  ·  Ivermectin (1)  ·  Nigella sativa oil (1)  ·  Saline Solution (1)  ·  Zinc (1)

Countries

Pakistan (4)

Top investigators

Moneeb Ashraf, MBBS (3)  ·  Muhammad Ashraf, PhD (3)  ·  Shoaib Ashraf, PhD (2)  ·  Ahmad Imran, MBBS (1)  ·  Qazi Abdul Saboor, MBBS (1)

Results publications

PMID 33568226, PMID 34488858, PMID 34526081, PMID 35045888